Wild-type p53 protein shows calcium-dependent binding to F-actin

被引:40
作者
Metcalfe, S
Weeds, A
Okorokov, AL
Milner, J
Cockman, M
Pope, B
机构
[1] Addenbrookes Hosp, Dept Surg, Cambridge CB2 2QQ, England
[2] MRC, Mol Biol Lab, Cambridge CB2 2QQ, England
[3] Univ York, YCRC P53 Lab, York YO1 5DD, N Yorkshire, England
基金
英国医学研究理事会;
关键词
p53; actin; calcium;
D O I
10.1038/sj.onc.1202559
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Nuclear localization of p53 is required for p53 to detect and respond to DNA strand abnormalities and breaks following DNA damage. This leads to activation of the tumour suppressive functions of p53 resulting in either cell cycle arrest and DNA repair; or apoptosis, Critical functional changes in DNA which require strand breaks, including gene rearrangement, may transiently mimic DNA damage: here it is important not to trigger a p53 response. The fine control of p53 in these different circumstances is unknown but may include transient sequestering of p53 in the cytoplasm, Reversible nuclear-cytoplasmic shuttling is an intrinsic property of p53 (Middeler et al,, 1997) associated with cell cycle-related changes in p53's subcellular distribution, Takahashi and Suzuki (1994) described p53 inactivation by shuttling to the cytoplasm and Katsumoto et al, (1995) found wildtype p53 to be closely associated,vith cytoplasmic actin filaments during DNA synthesis. Here we show that, in the presence of free calcium ions, p53 binds directly to F-actin with a dissocation constant of about 10 mu M. Thus, part of the regulatory machinery in normal cell cycling may involve p53-actin interactions regulated by calcium fluxes and the dynamic turnover of F-actin.
引用
收藏
页码:2351 / 2355
页数:5
相关论文
共 22 条
[1]
In vivo functions of actin-binding proteins [J].
Ayscough, KR .
CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (01) :102-111
[2]
Human smooth muscle α-actin gene is a transcriptional target of the p53 tumor suppressor protein [J].
Comer, KA ;
Dennis, PA ;
Armstrong, L ;
Catino, JJ ;
Kastan, MB ;
Kumar, CC .
ONCOGENE, 1998, 16 (10) :1299-1308
[3]
FOURIE AM, 1997, J BIOL CHEM, V272, P1947
[4]
GANNON JV, 1991, NATURE, V349, P802
[5]
p53 in growth control and neoplasia [J].
Gottlieb, TM ;
Oren, M .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3) :77-102
[6]
Guenal I, 1997, J CELL SCI, V110, P489
[7]
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 [J].
Honda, R ;
Tanaka, H ;
Yasuda, H .
FEBS LETTERS, 1997, 420 (01) :25-27
[8]
MEASUREMENT OF ACTIN CONCENTRATION IN SOLUTION - COMPARISON OF METHODS [J].
HOUK, TW ;
UE, K .
ANALYTICAL BIOCHEMISTRY, 1974, 62 (01) :66-74
[9]
Cell-cycle dependent biosynthesis and localization of p53 protein in untransformed human cells [J].
Katsumoto, T ;
Higaki, K ;
Ohno, K ;
Onodera, K .
BIOLOGY OF THE CELL, 1995, 84 (03) :167-173
[10]
Cytoplasmic retention of mutant tsp53 is dependent on an intermediate filament protein (Vimentin) scaffold [J].
Klotzsche, O ;
Etzrodt, D ;
Hohenberg, H ;
Bohn, W ;
Deppert, W .
ONCOGENE, 1998, 16 (26) :3423-3434